Search Medical Condition
Please enter condition
Please choose location from dropdown

Pregnancy Complications Clinical Trials

A listing of Pregnancy Complications medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1807) clinical trials

This study is to evaluate the safety of an existing diabetes drug and how it may help individuals with kidney disease. 

Phase

You screen their Internet access. You screen their movies. Have you screened their blood for increased risk of Type 1 diabetes? A blood test can identify risk for type 1 diabetes up to 10 years before symptoms appear. This test is offered at no cost to people who have a ...

Phase N/A

Type 1 Diabetes TrialNet, an international network of researchers exploring ways to prevent and delay the progression of type 1 diabetes, is taking great strides for type 1 diabetes. When you get involved in TrialNet research, you become part of a worldwide team that is working to find a way ...

Phase N/A

The purpose of this research study is to see if it is beneficial to treat high blood pressure during and after pregnancy NYU Winthrop Hospital Clinical Trials Center is seeking pregnant participants, who are 18 years old or older and who have been diagnosed with high blood pressure to participate ...

Phase N/A

The ATR(ataxia-telangiectasia and Rad3 related protein) inhibitor BAY1895344 is developed for the treatment of patients with advanced solid tumors and lymphomas. The purpose of the proposed trial is to evaluate the safety and tolerability of BAY1895344, and to identify the maximum tolerated dose of BAY1895344 that could be safely given ...

Phase

In patients with IDH1-R132X-mutant solid tumors treated with BAY1436032: 1. Determine the safety, tolerability, maximum tolerated dose (MTD) or recommended phase II dose (RP2D) of BAY1436032; 2. Evaluate the pharmacokinetic (PK) properties and pharmacodynamic (PD) effects of BAY1436032; 3. Look for preliminary evidence of clinical efficacy in patients treated with ...

Phase

To characterize the safety, tolerability, pharmacokinetics and immunogenicity of anetumab ravtansine in subjects with advanced solid cancers and with different degrees of hepatic or renal impairment

Phase

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of BAY 1251152 in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).

Phase

The relatively restricted C4.4a expression pattern provides a target for the selective delivery of a cytotoxic drug to C4.4.a-expressing tumor cells by means of a suitable antibody-drug conjugate. The subject population eligible for the current study will be those subjects with advanced malignancies known to express C4.4a, which are refractory ...

Phase